The breakthrough in drug delivery hinges on the development of nanoarchaeosomes, which are nanoparticles loaded with ...
One of the most significant challenges in cancer treatment is the development of drug resistance by cancer cells, which often leads to treatment failure. When we say the body "resists" cancer ...
A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...
A joint research team from the LKS Faculty of Medicine (HKUMed) and the Faculty of Science at the University of Hong Kong has uncovered an unexpected interaction between chemotherapeutic agents and a ...
Evidence has emerged about the way bacteria become resistant to multiple drugs. The findings by a John Innes Centre research ...
Microplastics (MPs) are widely distributed environmental pollutants around the world. Although studies have demonstrated that MPs have adverse effects on human health, the relationship between MPs and ...
Leerink Partnrs issued their Q3 2025 earnings estimates for Zentalis Pharmaceuticals in a report issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens forecasts that the company will ...
THIO sequenced with Libtayo extended overall survival in those with non–small cell lung cancer who progressed on two or more ...
3d
Interesting Engineering on MSNHealing touch: 7 plants that could hold the key to the future of medicineHere are seven medicinal plant species that have proved their worth in gold and may well have more to give to the future of ...
Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, biomarkers, and other cancer treatments, will be highlighted at the American ...
5d
Verywell Health on MSNA New 'Missile' Drug Is Approved To Treat the Most Common Breast Cancer TypeThe FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results